NHS Cancer Vaccine Launch Pad expanded to include trial for patients with advanced type of skin cancerPatients with an advanced type of skin melanoma in England will be given fast-track access to a “revolutionary” new cancer vaccine as part of an NHS trial.The vaccine, known as iSCIB1+ (ImmunoBody), helps the immune system recognise cancer cells and therefore better respond to immunotherapy treatment. Continue reading...